Showing results (91-100 of 3,350) with videos related to

Sort By:
Pageof 335
The Lancet. Oncology|May 1, 2007
Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective studySabine Tejpar, Hubert Piessevaux, Kathleen Claes, et al.
The Lancet. Oncology|May 1, 2007
Genetic predisposition for the development of radiation-associated meningioma: an epidemiological studyPazit Flint-Richter, Siegal Sadetzki
The Lancet. Oncology|June 6, 2006
Immunomodulating drugs for chronic lymphocytic leukaemiaAsher Chanan-Khan, Carl W Porter
The Lancet. Oncology|June 6, 2006
Where next for gefitinib in patients with lung cancer?Fiona Blackhall, Malcolm Ranson, Nick Thatcher
The Lancet. Oncology|June 6, 2006
Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? For the proposalAlberto Sobrero
The Lancet. Oncology|June 9, 2020
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trialJean-Yves Blay, César Serrano, Michael C Heinrich, et al.
The Lancet. Oncology|May 14, 2021
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort studyInes Pires da Silva, Tasnia Ahmed, Irene L M Reijers, et al.
The Lancet. Oncology|April 30, 2021
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational studyLeticia Monin, Adam G Laing, Miguel Muñoz-Ruiz, et al.
The Lancet. Oncology|June 2, 2020
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort studyJianbo Tian, Xianglin Yuan, Jun Xiao, et al.
The Lancet. Oncology|May 17, 2020
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyGhassan K Abou-Alfa, Teresa Macarulla, Milind M Javle, et al.
Pageof 335